|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM373979266 |
003 |
DE-627 |
005 |
20240723233301.0 |
007 |
cr uuu---uuuuu |
008 |
240624s2024 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2024.110287
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1479.xml
|
035 |
|
|
|a (DE-627)NLM373979266
|
035 |
|
|
|a (NLM)38909973
|
035 |
|
|
|a (PII)S1521-6616(24)00396-6
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Damara, Aman
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a LL37/self-DNA complexes mediate monocyte reprogramming
|
264 |
|
1 |
|c 2024
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 19.07.2024
|
500 |
|
|
|a Date Revised 22.07.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
|
520 |
|
|
|a LL37 alone and in complex with self-DNA triggers inflammatory responses in myeloid cells and plays a crucial role in the development of systemic autoimmune diseases, like psoriasis and systemic lupus erythematosus. We demonstrated that LL37/self-DNA complexes induce long-term metabolic and epigenetic changes in monocytes, enhancing their responsiveness to subsequent stimuli. Monocytes trained with LL37/self-DNA complexes and those derived from psoriatic patients exhibited heightened glycolytic and oxidative phosphorylation rates, elevated release of proinflammatory cytokines, and affected naïve CD4+ T cells. Additionally, KDM6A/B, a demethylase of lysine 27 on histone 3, was upregulated in psoriatic monocytes and monocytes treated with LL37/self-DNA complexes. Inhibition of KDM6A/B reversed the trained immune phenotype by reducing proinflammatory cytokine production, metabolic activity, and the induction of IL-17-producing T cells by LL37/self-DNA-treated monocytes. Our findings highlight the role of LL37/self-DNA-induced innate immune memory in psoriasis pathogenesis, uncovering its impact on monocyte and T cell dynamics
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a LL37/self-DNA complex
|
650 |
|
4 |
|a Metabolic and epigenetic modifications
|
650 |
|
4 |
|a Monocyte reprogramming
|
650 |
|
4 |
|a Psoriasis
|
650 |
|
7 |
|a Cathelicidins
|2 NLM
|
650 |
|
7 |
|a DNA
|2 NLM
|
650 |
|
7 |
|a 9007-49-2
|2 NLM
|
650 |
|
7 |
|a Antimicrobial Cationic Peptides
|2 NLM
|
650 |
|
7 |
|a Histone Demethylases
|2 NLM
|
650 |
|
7 |
|a EC 1.14.11.-
|2 NLM
|
650 |
|
7 |
|a Cytokines
|2 NLM
|
650 |
|
7 |
|a Jumonji Domain-Containing Histone Demethylases
|2 NLM
|
650 |
|
7 |
|a EC 1.14.11.-
|2 NLM
|
650 |
|
7 |
|a Interleukin-17
|2 NLM
|
700 |
1 |
|
|a Wegner, Joanna
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Trzeciak, Emily R
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kolb, Antonia
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Nastaranpour, Mahsa
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Khatri, Rahul
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tuettenberg, Andrea
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kramer, Daniela
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Grabbe, Stephan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Shahneh, Fatemeh
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 265(2024) vom: 21. Juli, Seite 110287
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:265
|g year:2024
|g day:21
|g month:07
|g pages:110287
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2024.110287
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 265
|j 2024
|b 21
|c 07
|h 110287
|